Study of pregnancy cancer risk after unusual DNA screening
Part of Cancer, Women’s health & pregnancy clinical trials.
This study follows pregnant people who had unusual noninvasive prenatal blood test results, to better understand the natural course and possible causes, including concerns about maternal cancer. You may join during pregnancy or up to 2 years after delivery, and you would share medical information and undergo follow-up visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older
- You had a blood noninvasive prenatal test (NIPT) with unusual or unclear results
- Your ultrasound looked normal and/or chromosome test (karyotype) was normal
- You can travel to the NIH for study visits
- You can understand the study and sign written consent (or have consent support if allowed)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how cancer and its treatment during pregnancy affect a pregnant person and their child. It may help doctors better plan care and follow-up for future pregnancies and growing children.
This study looks at people who have rare or unusual cancers or who may have an inherited (family) risk for cancer. It helps researchers learn what genetic or other factors might be involved by collecting family history and medical records, including pathology slides.
This study looks at a new blood test to screen for single-gene disorders (conditions caused by changes in one gene) during pregnancy. It may help if you or your baby's father carry a genetic disorder, or if an ultrasound shows signs of a possible genetic condition.
This study follows people after they had a NIPT blood test during pregnancy to better understand outcomes. If you were tested through Sequenom/Integrated Genetics and your pregnancy outcome is known, you may be eligible.
This study looks at a blood test done early in pregnancy (NIPT) to see if it can help predict conditions like preeclampsia, preterm labor, or gestational diabetes. If you had this test and had a healthy pregnancy or one of these complications, you may be able to join.
This study tests a new blood test that can screen for genetic problems in babies during pregnancy. It may find more conditions than standard tests, especially for pregnancies with certain ultrasound findings or other risk factors.
Hear when a new Maternal Neoplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.